JPRN-UMIN000007370已完成未知
The study of protective efficancy of postoprerative wound infection by Juzen-taiho-to after laryngo-tracheal separation - The protective efficancy of postoperative wound infection by Juzen-taiho-to
Tokyo University Pediatric Surgery0 个研究点目标入组 24 人开始时间: 2012年2月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The patients of Juzen-daiho-to administration befor this study 2) The patients need preparation with licorice 3) The patients need preparation with glycyrrhizic acid 4)Liver dysfunction 5)The other reasons, which doctor judge inappropriate patient
研究者
相似试验
已完成
3 期
A comparative study on the prophylactic effect of Dexmedetomidine and Paracetamol on intraoperative hemodynamic control and postoperative pain in patients undergoing laparoscopic cholecystectomyIRCT20180115038381N1Arak University of Medical Sciences132
已完成
3 期
comparison dexamethasone and meperidine on shiveringIRCT20240221061070N1Esfahan University of Medical Sciences45
已完成
不适用
The prospective study of the preventive effect of supraorbital transcutaneous stimulation using the Cefaly(R) device against frequent episodic migraine and chronic migraineMigraine with and without aura, including chronic migraine (ICHD-3beta 1.1, 1.2.1, or 1.3)JPRN-UMIN000033333Tominaga Hospital100
进行中（未招募）
1 期
An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study A” or Study B”) at Risk for Developing Sight-Threatening Choroidal Neovascularisation (CNV) Due to Exudative Age-Related Macular Degeneration (AMD). - Anecortave Acetate Risk Reduction Trial (AART)non-exudative age related macular degeneration (dry AMD)EUCTR2005-001598-93-ESAlcon Research Limited2,500
进行中（未招募）
不适用
An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study A” or Study B”) at Risk for Developing Sight-Threatening Choroidal Neovascularisation (CNV) Due to Exudative Age-Related Macular Degeneration (AMD) - Anecortave Acetate Risk Reduction Trial (AART)non-exudative age related macular degeneration (dry AMD)EUCTR2005-001598-93-DKAlcon Research Limited2,500